obstructive sleep apnea

sleep apnea CPAP CPAP machine
Pharma

Lilly's Zepbound scores 2nd FDA nod, this time in sleep apnea

With a new FDA green light, Eli Lilly’s Zepbound has become the first drug cleared to treat adults with obstructive sleep apnea and obesity.
Fraiser Kansteiner Dec 20, 2024 4:50pm
Zepbound tirzepatide

Lilly's Zepbound homes in on potential FDA sleep apnea nod

Jun 24, 2024 10:33am